Bone Density in Voluntary Apheresis Blood Donors

Completed · Not applicable

Conditions studied: Bone Density

In brief

A longitudinal, randomized, controlled, single-center Phase IV clinical trial will be performed to assess changes in bone mineral density (BMD) among voluntary apheresis blood donors. The primary outcome measure will be clinically significant decline in BMD at the lumbar spine assessed by dual-energy x-ray absorptiometry (DXA).

Key facts

Study ID
NCT02655055
Run by
Versiti Blood Health
People needed
58
Starts
2016-05-01
Expected to finish
2018-04-01
Last updated by the study team
2022-03-09

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.